Stock Analiz

NutriBand Inc. NTRB

Industrial Specialties · data as of November 13, 2026

$6.10Market cap $74M
Open the interactive analysis →

NutriBand Inc. (NTRB) is a healthcare company listed in the US with a market value of about $74M. In the twelve months to July 31, 2026 it had revenue of $2M and net income of -$7M, a net margin of -430.4%.

Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 17% a year, a 5-year average ROIC of -69%.

About NutriBand

NutriBand is listed in the US and classified in industrial specialties. Revenue went from $245285 in 2019 to $2M in 2026, growth of about 35.3% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 38% over three years (dilution for shareholders). It spends 93% of revenue on research and development.

Score: 0.8 / 5

Value0/5
Future growth1/5
Track record1/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • Strong R&D investment or growth above 20%
  • 5-year revenue growth above 8% a year
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S45.8
P/B13.9
EV/EBITDA—
PEG—
Dividend yield—
FCF yield-6.9%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)-4.8%
Revenue growth (5 yrs, per year)16.6%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-361.4%
ROIC (5-yr avg.)-68.7%
Profitable years (of last 10)0
Years paying a dividend1

Financials, last 10 years

Fiscal yearTTM2026202520242023202220212020201920182017
Revenue$2M$2M$2M$2M$2M$1M$943702$370647$245285——
Net income-$7M-$8M-$10M-$5M-$4M-$6M-$3M-$3M-$3M-$3M-$151260
Free cash flow—-$5M-$5M-$4M-$3M-$3M——-$1M——
EPS (diluted)$-0.53$-2.58$-0.99$-0.69$-0.53$-0.80$-0.51$-0.50$-0.62$-0.56$-0.04
Net margin-430.4%-404.1%-489.9%-263.0%-215.6%-434.3%-310.8%-734.3%-1358.1%——
ROIC—-94.9%-122.8%-45.0%-40.4%-40.2%-27.8%-388.5%-109.4%-1711.6%-484.0%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does NutriBand pay a dividend?

Not currently.

Is NutriBand a good stock to buy?

We do not give buy or sell advice. NutriBand scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.